Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides

Clinical trial NCT00400101 · TERMINATED

Trial details

NCT number: NCT00400101
Sponsor: Swiss Tropical & Public Health Institute
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Falciparum Malaria

Start date: 2003-11-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.